Fig 8 - by Velma K. Lopez (18510171)

The effect of instilling the ophthalmic solution on the LF/HF ratio and typical cases of fluctuations in the LF/HF ratio over time in the DE and non-DE groups. by Minako Kaido (309626)

Post-stimulus undershoot and vasomotion persist with different GC activation levels. by William Davis Haselden (9175156)

Effects of vidarabine, V2E, V3E and V5E on AC activity in the heart of WT and AC5KO mice. by Kenji Suita (750993)

Data_Sheet_1_Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in NFKB2.docx by Christian Klemann (3779056)

“…Immunophenotyping showed largely normal or even increased quantities of naïve and memory CD4⁺ or CD8⁺ T-cells and normal T-cell proliferation. …”

Table_1_Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in NFKB2.xlsx by Christian Klemann (3779056)

“…Immunophenotyping showed largely normal or even increased quantities of naïve and memory CD4⁺ or CD8⁺ T-cells and normal T-cell proliferation. …”

Results from the virtual experiment using the diffusion model. by Honghan Li (19332798)

Datasheet1_Clinical effect of limited posterior decompression and 13-mm titanium mesh implantation on severe thoracolumbar burst fractures: A case series.docx by Liu Jingcheng (14799472)

“…The American Association of Spinal Injury improved after surgery (A/B/C/D/E: from 2/6/5/2/0 to 0/0/2/8/5, P < 0.001). …”

Image_1_Case Report: Cardiac Tamponade in Association With Cytokine Release Syndrome Following CAR-T Cell Therapy.TIFF by Shohei Moriyama (6924746)

“…</p>Case Summary<p>A 59-year-old man with refractory diffuse large B-cell lymphoma underwent CAR-T cell therapy. …”

Image_2_Case Report: Cardiac Tamponade in Association With Cytokine Release Syndrome Following CAR-T Cell Therapy.TIFF by Shohei Moriyama (6924746)

“…</p>Case Summary<p>A 59-year-old man with refractory diffuse large B-cell lymphoma underwent CAR-T cell therapy. …”

Video_3_Case Report: Cardiac Tamponade in Association With Cytokine Release Syndrome Following CAR-T Cell Therapy.MP4 by Shohei Moriyama (6924746)

“…</p>Case Summary<p>A 59-year-old man with refractory diffuse large B-cell lymphoma underwent CAR-T cell therapy. …”

Video_5_Case Report: Cardiac Tamponade in Association With Cytokine Release Syndrome Following CAR-T Cell Therapy.MP4 by Shohei Moriyama (6924746)

“…</p>Case Summary<p>A 59-year-old man with refractory diffuse large B-cell lymphoma underwent CAR-T cell therapy. …”

Video_1_Case Report: Cardiac Tamponade in Association With Cytokine Release Syndrome Following CAR-T Cell Therapy.MP4 by Shohei Moriyama (6924746)

“…</p>Case Summary<p>A 59-year-old man with refractory diffuse large B-cell lymphoma underwent CAR-T cell therapy. …”

Video_2_Case Report: Cardiac Tamponade in Association With Cytokine Release Syndrome Following CAR-T Cell Therapy.MP4 by Shohei Moriyama (6924746)

“…</p>Case Summary<p>A 59-year-old man with refractory diffuse large B-cell lymphoma underwent CAR-T cell therapy. …”

Video_4_Case Report: Cardiac Tamponade in Association With Cytokine Release Syndrome Following CAR-T Cell Therapy.MP4 by Shohei Moriyama (6924746)

“…</p>Case Summary<p>A 59-year-old man with refractory diffuse large B-cell lymphoma underwent CAR-T cell therapy. …”

DataSheet1_Long-term change of the eruption activities of Sakurajima volcano, Japan, inferred from the fallout tephra deposits.PDF by Ayumu Nishihara (14173077)

“…Among them, Stage 2a (13–8 ka) produced the largest volume of tephra fallout deposits, suggesting that Sakurajima peaked in magma discharge during Stage 2a (2.9 km³/kyr) and then decreased rapidly toward Stage 2b (8–4.8 ka; 0.07 km³/kyr). …”

DataSheet3_Long-term change of the eruption activities of Sakurajima volcano, Japan, inferred from the fallout tephra deposits.PDF by Ayumu Nishihara (14173077)

“…Among them, Stage 2a (13–8 ka) produced the largest volume of tephra fallout deposits, suggesting that Sakurajima peaked in magma discharge during Stage 2a (2.9 km³/kyr) and then decreased rapidly toward Stage 2b (8–4.8 ka; 0.07 km³/kyr). …”

Table1_Long-term change of the eruption activities of Sakurajima volcano, Japan, inferred from the fallout tephra deposits.XLSX by Ayumu Nishihara (14173077)

“…Among them, Stage 2a (13–8 ka) produced the largest volume of tephra fallout deposits, suggesting that Sakurajima peaked in magma discharge during Stage 2a (2.9 km³/kyr) and then decreased rapidly toward Stage 2b (8–4.8 ka; 0.07 km³/kyr). …”

DataSheet2_Long-term change of the eruption activities of Sakurajima volcano, Japan, inferred from the fallout tephra deposits.PDF by Ayumu Nishihara (14173077)

“…Among them, Stage 2a (13–8 ka) produced the largest volume of tephra fallout deposits, suggesting that Sakurajima peaked in magma discharge during Stage 2a (2.9 km³/kyr) and then decreased rapidly toward Stage 2b (8–4.8 ka; 0.07 km³/kyr). …”

Update on trimethylamine N-oxide (TMAO) as a piezolyte and cryoprotectant: its role in a depth limit for marine fishes and loss from hadal fish during capture by Paul Yancey (14354982)

“…</p><p dir="ltr">Jamieson AJ, Yancey PH (2012). doi/10.1086/BBLv222n3p171</p><p dir="ltr">Lantz C, Xi Z, Rider RL, Walker TE, Hebert M, Russell DH (2024). doi.org/10.1021/acs.jpcb.4c04951</p><p dir="ltr">Laurent H, Youngs TGA, Headen TF, Soper AK, Dougan L (2022). doi.org/10.1038/s42004-022-00726-z</p><p dir="ltr">Li X, Wang C, Yanagita T, Xue C, Zhang T, Wang Y (2024). doi.org/10.1021/acs.jafc.4c01974</p><p dir="ltr">Linley T, Gerringer M, Yancey PH, Drazen JC, Weinstock C, Jamieson A (2016). doi.org/10.1016/j.dsr.2016.05.003</p><p dir="ltr">Liu Q, Jiang S, Li W, Pan B, Xu Q (2022). doi.org/10.3390/jmse10040454</p><p dir="ltr">Liu T-H, Okuno M (2024). doi.org/10.1039/D4CP01025F</p><p dir="ltr">Loo RL, Chan Q, Nicholson JK, Holmes E (2022). doi.org/10.1021/acs.jproteome.1c00851</p><p dir="ltr">Mueller-Dieckmann C, Kauffmann B, Weiss MS (2011). doi.org/10.1107/S0021889811000</p><p dir="ltr">Mu Y, Bian C, Liu R, Wang Y, Shao G, Li J, et al. (2021). doi.org/10.1371/journal.pgen.1009530</p><p dir="ltr">Raymond JA, Devries AL (1998). doi.org/10.1023/a:1007778728627</p><p dir="ltr">Raymond JA, Hassel A (2005). doi.org/10.1111/j.1095-8649.2000.tb02240.x</p><p dir="ltr">Roche J, Royer CA (2018). doi.org/10.1098/rsif.2018.0244</p><p dir="ltr">Samerotte AL, Drazen JC, Brand GL, Seibel BA, Yancey PH (2007). doi/10.1086/510566</p><p dir="ltr">Swan JA, Jamieson AJ, Linley TD, Yancey PH (2021). doi.org/10.1093/jcbiol/ruaa102</p><p dir="ltr">Treberg JR, Bystriansky JS, Driedzic WR (2005). doi.org/10.1002/jez.a.140</p><p dir="ltr">Wang K, Shen Y, Yang Y, Gan X, Liu G, Hu K, et al. (2019). doi.org/10.1038/s41559-019-0864-8</p><p dir="ltr">Xu H, Fang C, Xu W, Wang C, Song Y, Zhu C, et al. (2025). doi.org/10.1016/j.cell.2025.01.002</p><p dir="ltr">Yancey PH, Speers-Roesch B, Atchison A, Reist JD., Treberg JR (2018). doi.org/10.1086/696157</p><p dir="ltr">Yancey PH (2020). doi.org/10.1002/jez.2354</p><p dir="ltr">Yancey PH (2023). doi/10.33594/000000661</p>…”